Palisade Bio (PALI)
NASDAQ:PALI

Palisade Bio (PALI) Financial Statements

456 Followers

Palisade Bio Financial Overview

Palisade Bio's market cap is currently ―. The company's EPS TTM is $-24.706; its P/E ratio is -0.18; Palisade Bio is scheduled to report earnings on August 20, 2024, and the estimated EPS forecast is $-2.93. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue----$ 250.00K
Gross Profit----$ 250.00K
EBIT$ -3.53M$ -3.69M$ -2.86M$ -3.39M$ -2.34M
EBITDA$ -3.52M$ -3.69M$ -2.86M$ -3.39M$ -2.34M
Net Income Common Stockholders$ -3.53M$ -3.71M$ -2.87M$ -3.39M$ -2.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.28M$ 12.43M$ 15.31M$ 16.40M$ 13.30M
Total Assets$ 12.65M$ 14.05M$ 17.07M$ 18.29M$ 15.25M
Total Debt$ 183.00K$ 211.00K$ 498.00K$ 677.00K$ 291.00K
Net Debt$ -11.09M$ -12.22M$ -14.81M$ -15.73M$ -13.01M
Total Liabilities$ 2.59M$ 2.74M$ 2.98M$ 2.49M$ 1.51M
Stockholders Equity$ 10.06M$ 11.31M$ 14.08M$ 15.80M$ 13.75M
Cash Flow-
Free Cash Flow$ -3.18M$ -2.75M$ -2.66M$ -2.20M$ -3.53M
Operating Cash Flow$ -3.18M$ -2.75M$ -2.66M$ -2.20M$ -3.53M
Investing Cash Flow---$ -4.00K-
Financing Cash Flow$ 2.02M$ -134.00K$ 1.57M$ 5.31M$ 4.44M
Currency in USD

Palisade Bio Earnings and Revenue History

Palisade Bio Debt to Assets

Palisade Bio Cash Flow

Palisade Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis